Efficacy and Safety of Colchicine in Pediatric Pericarditis: A Systematic Review and Future Directions

Alsabri, Mohammed; Elsayed, Sarah Makram; Elsnhory, Ahmed Bostamy; Abouelmagd, Khaled; Ayyad, Mohammed; Alqeeq, Basel F.; Siddiq, Abdelmonem; Soliman, Yousef; Shahid, Muhammad Azan

doi:10.1007/s00246-024-03606-6

Pediatr Cardiol

2024

DOI: 10.1007/s00246-024-03606-6

|View full text |Cite

Efficacy and Safety of Colchicine in Pediatric Pericarditis: A Systematic Review and Future Directions

Mohammed Alsabri,

Sarah Makram Elsayed,

Ahmed Bostamy Elsnhory

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Commentary on “Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses”

Mehta,

Balaraman,

Shabil

et al. 2024

Pediatr Cardiol

View full text Add to dashboard Cite

Commentary on “Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses”

Mehta,

Balaraman,

Shabil

et al. 2024

Pediatr Cardiol

View full text Add to dashboard Cite

Colchicine: Repositioning an “ancient” medicine in the 21st century

Nasonov,

Drapkina

2024

Naučno-praktičeskaâ revmatologiâ

View full text Add to dashboard Cite

The main indications for colchicine treatment until recently were gout, pericarditis, familial Mediterranean fever and some other auto-inflammatory diseases. The expansion of indications (repositioning) for the use of colchicine in the direction of prevention of cardiovascular complications should be considered as one of the major events in medicine of the XXI century. Deciphering the role of inflammation as the most important mechanism for the development of atherosclerosis has created prerequisites for the development of the concept of anti-inflammatory therapy of atherosclerosis, in which low-dose colchicine therapy can take an important place, complementing the effects of aspirin, statins and antihypertensive therapy. The analysis of materials from randomized placebo-controlled studies of colchicine indicates a decrease in the frequency of cardiovascular complications in patients with coronary heart disease (by 31%) and in patients who have recently suffered a myocardial infarction (by 23%), as well as myocardial infarction (by 33%), stroke, the need for myocardial revascularization and cardiovascular mortality. The use of colchicine in a low dose (0.5 mg/day) is approved by the U.S. Food and Drug Administration for the prevention of cardiovascular complications in patients with coronary heart disease. It can be assumed that in the future colchicine will take an important place in the prevention and treatment of cardiovascular pathology associated with atherosclerotic vascular disease.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Efficacy and Safety of Colchicine in Pediatric Pericarditis: A Systematic Review and Future Directions

Cited by 2 publications

References 33 publications

Commentary on “Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses”

Commentary on “Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses”

Colchicine: Repositioning an “ancient” medicine in the 21st century

Contact Info

Product

Resources

About